Objetivo
EUGeneHeart will develop new approaches to prevent and treat heart failure through analysis of the genomics of signalling. Our strategy is based on the hypothesis that beneficial and maladaptive forms of hypertrophy exist and that heart failure is frequently preceded by maladaptive hypertrophy. We will dissect both adaptive and maladaptive signalling in hypertrophy to identify beneficial and maladaptive components of signal transduction in hypertrophy and heart failure. The EUGeneHeart consortium forms an extremely integrated project comprised of six major tasks. In Task 1, murine models will be analysed (phenotyped) in an integrated matrix approach: Wildtype mice will be subjected to pressure overload, myocardial infarction, and chronic exercise, genetically modified mice with a beneficial response to these stressors will be compared for differences in signal transduction. Task 2 identifies new players in different forms of hypertrophy and failure using screening techniques including proteomics and microarrays, forward and reverse genetics in drosophila and zebrafish, validation in murine models and patient cohorts. Task 3 exploits knowledge generated in the first two tasks and translates knowledge on existing pharmacological interventions to generate new candidate drugs in close involvement of SME's. Candidate small molecules and molecule libraries will be tested in a successive developmental platform. This will lead to patent filing, licensing strategies and to phase I and II clinical trials. Task 4 contains specific questions related to sex differences and to signalling in hypertrophy. Our approach takes account of national research activities and recruits knowledge, patients and tissues at a European level.Task 5 includes a training initiative and Task 6 contains the Management activities of the project. The ultimate accomplishment will include improvement of health, reduction of health expenses,creation of new jobs and economic benefit.
Ámbito científico
Convocatoria de propuestas
FP6-2004-LIFESCIHEALTH-5
Consulte otros proyectos de esta convocatoria
Régimen de financiación
IP - Integrated ProjectCoordinador
GOETTINGEN
Alemania
Ver en el mapa
Participantes (21)
LOUVAIN-LA-NEUVE
Ver en el mapa
ROME
Ver en el mapa
UTRECHT
Ver en el mapa
85500 UTRECHT
Ver en el mapa
HAMBURG
Ver en el mapa
PARIS
Ver en el mapa
SZEGED
Ver en el mapa
BERLIN
Ver en el mapa
LONDON
Ver en el mapa
LEUVEN
Ver en el mapa
TORINO
Ver en el mapa
616 MAASTRICHT
Ver en el mapa
STOCKHOLM
Ver en el mapa
OXFORD
Ver en el mapa
BRATISLAVA
Ver en el mapa
LYON
Ver en el mapa
ORLÉANS
Ver en el mapa
VIENNA
Ver en el mapa
VIENNA
Ver en el mapa
LYON
Ver en el mapa
SAARBRÜCKEN
Ver en el mapa